Correction for Robbesyn et al., Arterioscler Thromb Vasc Biol 25 (6) 1206-1212.

This Article Extract Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Search for Related Content

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:e128.)
© 2005 American Heart Association, Inc.

Correction

In the June 2005 issue of Arteriosclerosis, Thrombosis, and Vascular Biology, in the article by Robbesyn et al (Arterioscler Thromb Vasc Biol. 2005:25:1206–1212.), EGF was incorrectly spelled out in the title, abstract, and introduction as "endothelial growth factor."

The abbreviation should have been expanded as "epidermal growth factor." The publisher regrets this error.

This article has been cited by other articles:

				A. Kontush and M. J. Chapman Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis Pharmacol. Rev., September 1, 2006; 58(3): 342 - 374. [Abstract] [Full Text] [PDF]

This Article Extract Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Search for Related Content